Six Reasons Joint Guardian May Help Ease Your Aching Joints

Published : 01/26/2017 13:39:26
Categories : Healthy Heart , Healthy Living , Mens Health , Womens Health

1. Pain Relief

Joint Guardian includes natural ingredients that have been shown in controlled studies to reduce joint pain. Boswellia serrata extract, chondroitin, ginger (Zingiber officiale), glucosamine and methylsulfonylmethane (MSM), all of which are components of Joint Guardian, have been shown to significantly reduce pain as compared to placebo in people with osteoarthritis. In fact, glucosamine and chondroitin appear to be as effective for pain relief as non-steroidal anti-inflammatory drugs that are commonly prescribed for osteoarthritis.

2. Cartilage Protection

Cartilage is the connective tissue that protects the ends of the long bones at the joints. Breakdown of this tissue is one of the hallmarks of osteoarthritis and can lead to joint pain, swelling and stiffness. In addition to reducing pain, glucosamine and chondroitin appear to protect against the destruction of cartilage in people who have, or are at risk for, osteoarthritis.

3. Reduced Deterioration of Joints

As osteoarthritis progresses and the condition worsens, the space between the joints narrows. In clinical studies, people with arthritis who took glucosamine and/or chondroitin had less joint space narrowing over time, as compared to people who took a placebo pill.

4. Improvement in Function

Arthritis and joint pain can have an important impact on physical functioning and the ability to complete everyday tasks, such as climbing the stairs, getting in and out of the car, or putting on socks. Several natural remedies, including glucosamine, chondroitin, ginger and MSM, have been shown to help significantly improve function in people suffering from osteoarthritis.

5. Less need for Other Medical Interventions

Long-term studies suggest that arthritis patients who were prescribed glucosamine and chondroitin not only needed to use less pain medications, but required fewer doctor’s visits and were less likely to end up having knee replacement surgery.

6. Expert Recommendation

Based on this preponderance of evidence, the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, an international group of expert physicians and researchers, recently recommended that glucosamine and chondroitin be used as a first-line treatment for patients with osteoarthritis of the knee.

References:

Bartels EM, et al. Efficacy and safety of ginger in osteoarthritis patients: a meta-analysis of randomized placebo-controlled trials. Osteoarthritis and Cartilage 2015;23:13–21.

Brien S, et al. Systematic review of the nutritional supplements dimethyl sulfoxide (DMSO) and methylsulfonylmethane (MSM) in the treatment of osteoarthritis. Osteoarthritis and Cartilage 2008;16:1277–88.

Bruyere O, et al. Total joint replacement after glucosamine sulphate treatment in knee osteoarthritis: results of a mean 8-year observation of patients from two previous 3-year, randomised, placebo-controlled trials. Osteoarthritis and Cartilage 2008;16:254–60.

Bruyère O, et al. A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis — from evidence-based medicine to the real-life setting. Seminars in Arthritis and Rheumatism 2016;45:S3–11.

Cameron M, Chrubasik S. Oral herbal therapies for treating osteoarthritis. Cochrane Database of Systematic Reviews 2014;5:CD002947.

Gallagher B, et al. Chondroprotection and the prevention of osteoarthritis progression of the knee: a systematic review of treatment agents. American Journal of Sports Medicine 2015;43:734–44.

Kongtharvonskul J, et al. Efficacy and safety of glucosamine, diacerein, and NSAIDs in osteoarthritis knee: a systematic review and network meta-analysis. European Journal of Medical Research 2015;20:24.

Zeng C, et al. Effectiveness and safety of glucosamine, chondroitin, the two in combination, or celecoxib in the treatment of osteoarthritis of the knee. Scientific Reports 2015;5:16827.

Share this content